Horizon Space Acquisition II Corp. (HSPT) Form SCHEDULE 13D/A — Jun 17, 2026
Horizon Space Acquisition II Corp. has filed an amended Schedule 13D disclosing details of its planned business combination with SL BIO Ltd., a Cayman Islands exempted company. The agreement, dated May 9, 2025, establishes a two-step merger process with multiple special purpose entities. The transaction structure involves Merger Sub I merging with Horizon Space Acquisition II Corp., followed by Merger Sub II merging with SL BIO Ltd.
Key figures
- Private units
- 200000
- Sponsor shares
- 1725000
- Per share price
- $10.00
- Enterprise value
- $5.568 billion
- Target shares outstanding
- 3675000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.